The essential role played by PTP1B inhibition in the anti-obesity and antidiabetic activities of trodusquemine was confirmed by studies on the LIM domain only 4 (LMO4) protein, an endogenous negative regulator of PTP1B. This evidence concerns the gene LMO4 and obesity disorder.